Autopsy and Case Reports
https://www.autopsyandcasereports.org/article/doi/10.4322/acr.2021.312
Autopsy and Case Reports
Clinical Case Report

IgG4-related Disease: a diagnostic challenge

Rodrigo Díaz Olmos; Marcelo Arlindo Vasconcelos Miranda Rodrigues; Cristiane Rúbia Ferreira; Rita de Cássia Franco Etrusco; Carla Romagnolli

Downloads: 0
Views: 943

Abstract

Immunoglobulin IgG4-related disease (IgG4-RD) is an immune-mediated fibroinflammatory condition with a characteristic histopathological appearance that can affect almost any organ. The clinical features result from a focal or diffuse appearance of a tumor-like swelling of the affected organs, identified by physical and/or imaging examination. Herein, we report the case of a 38-year-old male complaining of a worsening chronic right lumbar pain associated with legs and scrotum edema. He also had itchy and erythematous cutaneous lesions on the abdominal wall over the last 8 months, and complained of a diffuse and mild to moderate abdominal discomfort. On examination, the liver was firmly enlarged and tender. His legs had 2+ symmetrical pitting edema extending from his feet to just above the knees. An abdominal computed tomography scan showed a large mass (10 x 8 x 4cm) involving the abdominal infrarenal aorta and the iliac arteries, and compressing the inferior vena cava, with dilated iliac veins, raising the possibility of lymphoproliferative disease. During the initial investigation, the laboratory workup revealed anemia, without other marked changes. A laparoscopic-guided biopsy of the peri-aortic mass was undertaken. The histological report associated with IgG4 immunoglobulin measurement rendered the diagnosis of IgG4-RD. The patient had a favorable outcome after the use of glucocorticoids with the abdominal mass remission.

Keywords

Immunoglobulin G, Immunoglobulin G4-Related Disease, Lymph Node Excision

References

1 Stone JH, Zen Y, Deshpande V. IgG4-Related Disease. N Engl J Med. 2012;366(6):539-51. http://dx.doi.org/10.1056/NEJMra1104650. PMid:22316447.

2 Deshpande V, Zen Y, Chan JK, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012;25(9):1181-92. http://dx.doi.org/10.1038/modpathol.2012.72. PMid:22596100.

3 Umehara H, Okazaki K, Masaki Y, et al. A novel clinical entity, IgG4- related disease (IgG4RD): general concept and details. Mod Rheumatol. 2012;22(1):1-14. http://dx.doi.org/10.3109/s10165-011-0508-6. PMid:21881964.

4 Chen LYC, Mattman A, Seidman MA, Carruthers MN. IgG4-related disease: what a hematologist needs to know. Haematologica. 2019;104(3):444-55. http://dx.doi.org/10.3324/haematol.2018.205526. PMid:30705099.

5 Yamada K, Yamamoto M, Saeki T, et al. New clues to the nature of immunoglobulin G4-related disease: a retrospective Japanese multicenter study of baseline clinical features of 334 cases. Arthritis Res Ther. 2017;19(1):262. http://dx.doi.org/10.1186/s13075-017-1467-x. PMid:29191210.

6 Inoue D, Yoshida K, Yoneda N, et al. IgG4-related disease: dataset of 235 consecutive patients. Medicine. 2015;94(15):e680. http://dx.doi.org/10.1097/MD.0000000000000680. PMid:25881845.

7 Chen Y, Zhao JZ, Feng RE, et al. Types of organ involvement in patients with immunoglobulin G4- related disease. Chin Med J. 2016;129(13):1525-32. http://dx.doi.org/10.4103/0366-6999.184459. PMid:27364787.

8 Sekiguchi H, Horie R, Kanai M, Suzuki R, Yi ES, Ryu JH. IgG4- related disease: retrospective analysis of one hundred sixty-six patients. Arthritis Rheumatol. 2016;68(9):2290-9. http://dx.doi.org/10.1002/art.39686. PMid:26990055.

9 Wallace ZS, Deshpande V, Mattoo H, et al. IgG4-related disease: clinical and laboratory features in one hundred twenty-five patients. Arthritis Rheumatol. 2015;67(9):2466-75. http://dx.doi.org/10.1002/art.39205. PMid:25988916.

10 Lin W, Lu S, Chen H, et al. Clinical characteristics of immunoglobulin G4-related disease: a prospective study of 118 Chinese patients. Rheumatology. 2015;54(11):1982-90. http://dx.doi.org/10.1093/rheumatology/kev203. PMid:26106212.

11 Zen Y, Nakanuma Y. IgG4-related disease: a cross-sectional study of 114 cases. Am J Surg Pathol. 2010;34(12):1812-9. http://dx.doi.org/10.1097/PAS.0b013e3181f7266b. PMid:21107087.

12 Fernández-Codina A, Martínez-Valle F, Pinilla B, et al. IgG4- related disease: results from a multicenter Spanish Registry. Medicine. 2015;94(32):e1275. http://dx.doi.org/10.1097/MD.0000000000001275. PMid:26266361.

13 Mizushima I, Inoue D, Kawano M. Retroperitoneal fibrosis/periaortitis and hydronephrosis. In: Saito T, Stone JH, Nakashima H, Saeki T, Kawano M, editors. IgG4-related kidney disease. Tokyo: Springer; 2016. p. 159-71. http://dx.doi.org/10.1007/978-4-431-55687-9_14.

14 Kawano M, Saeki T, Nakashima H. IgG4-related kidney disease and retroperitoneal fibrosis: an update. Mod Rheumatol. 2019;29(2):231-9. http://dx.doi.org/10.1080/14397595.2018.1554321. PMid:30499730.

15 Engelhart S, Glynn RJ, Schur PH. Disease associations with isolated elevation of each of the four IgG subclasses. Semin Arthritis Rheum. 2017;47(2):276-80. http://dx.doi.org/10.1016/j.semarthrit.2017.03.021. PMid:28457528.

16 Della Torre E, Mattoo H, Mahajan VS, Carruthers M, Pillai S, Stone JH. Prevalence of atopy, eosinophilia, and IgE elevation in IgG4- related disease. Allergy. 2014;69(2):269-72. http://dx.doi.org/10.1111/all.12320. PMid:24266692.

17 Umehara H, Okazaki K, Masaki Y, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD). Mod Rheumatol. 2012;22(1):21-30. http://dx.doi.org/10.3109/s10165-011-0571-z. PMid:22218969.

18 Mahajan VS, Mattoo H, Deshpande V, Pillai SS, Stone JH. IgG4- related disease. Annu Rev Pathol. 2014;9(1):315-47. http://dx.doi.org/10.1146/annurev-pathol-012513-104708. PMid:24111912.

19 Guma M, Firestein GS. IgG4-related diseases. Best Pract Res Clin Rheumatol. 2012;26(4):425-38. http://dx.doi.org/10.1016/j.berh.2012.07.001. PMid:23040358.

20 Perugino CA, Stone JH. Treatment of IgG4-related disease: current and future approaches. Z Rheumatol. 2016;75(7):681-6. http://dx.doi.org/10.1007/s00393-016-0142-y. PMid:27431746.

21 Perugino CA, Stone JH. IgG4-related disease: an update on pathophysiology and implications for clinical care. Nat Rev Rheumatol. 2020;16(12):702-14. http://dx.doi.org/10.1038/s41584-020-0500-7. PMid:32939060.

22 Zhang W, Stone JH. Management of IgG4-related disease. Lancet Rheum. 2019;1(1):E55-65. http://dx.doi.org/10.1016/S2665-9913(19)30017-7.

23 Khosroshahi A, Wallace ZA, Crowe JL, et al. International consensus guidance statement on the management and treatment of IgG4-related disease. Arthritis Rheumatol. 2015;67(7):1688-99. http://dx.doi.org/10.1002/art.39132. PMid:25809420.

24 Hart PA, Topazian MD, Witzig TE, et al. Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience. Gut. 2013;62(11):1607-15. http://dx.doi.org/10.1136/gutjnl-2012-302886. PMid:22936672.
 


Submitted date:
05/19/2021

Accepted date:
06/25/2021

Publication date:
08/20/2021

611fadeea953955ce65b5655 autopsy Articles
Links & Downloads

Autops Case Rep

Share this page
Page Sections